Results
9
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
9 companies
SAINT BELLA
Market Cap: HK$4.6b
Provides postpartum care and recovery services in the Cayman Islands, Hong Kong, Singapore, and China.
2508
HK$7.14
7D
-7.5%
1Y
n/a
Zylox-Tonbridge Medical Technology
Market Cap: HK$6.9b
A medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally.
2190
HK$22.36
7D
-1.5%
1Y
120.1%
MicroTech Medical (Hangzhou)
Market Cap: HK$2.8b
Provides diabetes management, diabetes treatment, and diabetes monitoring medical devices in China and internationally.
2235
HK$6.78
7D
-2.4%
1Y
77.0%
New Horizon Health
Market Cap: HK$6.3b
An investment holding company, engages in the research and development of screening products for colorectal, cervical, and other types of cancer in the People’s Republic of China.
6606
HK$14.14
7D
0%
1Y
-52.3%
Jiangxi Rimag Group
Market Cap: HK$5.7b
Invests and operates medical imaging centers in China.
2522
HK$16.56
7D
4.3%
1Y
-8.5%
Adicon Holdings
Market Cap: HK$5.4b
An investment holding company, provides medical testing services in the People’s Republic of China.
9860
HK$7.67
7D
0.8%
1Y
-9.6%
Yidu Tech
Market Cap: HK$6.5b
An investment holding company, provides healthcare solutions built on big data and artificial intelligence (AI) technologies in the People’s Republic of China, Brunei, Singapore, and internationally.
2158
HK$6.49
7D
-0.5%
1Y
96.1%
Angelalign Technology
Market Cap: HK$11.2b
An investment holding company, researches and designs, manufactures, sells, and markets clear aligner treatment solutions in the People’s Republic of China and internationally.
6699
HK$67.30
7D
-0.4%
1Y
27.2%
YSB
Market Cap: HK$6.2b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$9.74
7D
0%
1Y
27.2%